To review pharmacist-led screening programmes for estimation of cardiovascular\r\ndisease (CVD) risk using validated screening tools, studies were identified using a search\r\nof the following electronic databases: PubMed, EMBASE, Web of Knowledge and the\r\nCochrane library databases. Each database was searched from inception to December 2011.\r\nThe search terms used were: ââ?¬Å?cardiovascular diseaseââ?¬Â, ââ?¬Å?screeningââ?¬Â, ââ?¬Å?risk estimationââ?¬Â,\r\nââ?¬Å?pharmacistââ?¬Â and ââ?¬Å?pharmacyââ?¬Â. Titles, abstracts and full manuscripts were screened to\r\ndetermine eligibility. Inclusion criteria were: (i) Pharmacist-led CVD screening; and (ii) Use\r\nof validated screening tool or tools for CVD. From each included study information was\r\ncollected on the following: Study author; year of publication; setting; inclusion and exclusion\r\ncriteria; tools used and outcomes measured. Articles were grouped and independently\r\nverified to ensure they met with the inclusion criteria. Over 7,000 citations were found.\r\nTwenty full-length articles were retrieved for analysis, of which twelve were excluded, as\r\nthey did not meet the inclusion criteria. The eight remaining articles were included in this\r\nliterature review. Whilst pharmacists undertake screening in their own practice, this\r\napproach will only go so far. To have a population-health impact, pharmacists should be\r\ninvolved in proactive screening in a variety of settings.
Loading....